コンテンツへスキップ
Merck
  • Biomechanical properties of the thoracic aneurysmal wall: differences between bicuspid aortic valve and tricuspid aortic valve patients.

Biomechanical properties of the thoracic aneurysmal wall: differences between bicuspid aortic valve and tricuspid aortic valve patients.

The Annals of thoracic surgery (2014-06-03)
Caroline Forsell, Hanna M Björck, Per Eriksson, Anders Franco-Cereceda, T Christian Gasser
要旨

The prevalence for thoracic aortic aneurysms (TAAs) is significantly increased in patients with a bicuspid aortic valve (BAV) compared with patients who have a normal tricuspid aortic valve (TAV). TAA rupture is a life-threatening event, and biomechanics-based simulations of the aorta may help to disentangle the molecular mechanism behind its development and progression. The present study used polarized microscopy and macroscopic in vitro tensile testing to explore collagen organization and mechanical properties of TAA wall specimens from BAV and TAV patients. Circumferential sections of aneurysmal aortic tissue from BAV and TAV patients were obtained during elective operations. The distribution of collagen orientation was captured by a Bingham distribution, and finite element models were used to estimate constitutive model parameters from experimental load-displacement curves. Collagen orientation was almost identical in BAV and TAV patients, with a highest probability of alignment along the circumferential direction. The strength was almost two times higher in BAV samples (0.834 MPa) than in TAV samples (0.443 MPa; p<0.001). The collagen-related stiffness (Cf) was significantly increased in BAV compared with TAV patients (Cf=7.45 MPa vs 3.40 MPa; p=0.003), whereas the elastin-related stiffness was similar in both groups. A trend toward a decreased wall thickness was seen in BAV patients (p=0.058). The aneurysmal aortas of BAV patients show a higher macroscopic strength, mainly due to an increased collagen-related stiffness, compared with TAV patients. The increased wall stiffness in BAV patients may contribute to the higher prevalence for TAAs in this group.

材料
製品番号
ブランド
製品内容

Sigma-Aldrich
コラーゲン ヒト胎盤由来, Bornstein and Traub Type IV, powder, BioReagent, suitable for cell culture
Sigma-Aldrich
コラーゲン, I型 溶液 from rat tail, BioReagent, suitable for cell culture, sterile-filtered
Sigma-Aldrich
コラーゲン from calf skin, Bornstein and Traub Type I, solid, BioReagent, suitable for cell culture
Sigma-Aldrich
コラーゲン from rat tail, Bornstein and Traub Type I, powder, BioReagent, suitable for cell culture
Sigma-Aldrich
コラーゲン ヒト胎盤由来, Bornstein and Traub Type IV, powder
Sigma-Aldrich
コラーゲン from bovine achilles tendon, powder, suitable for substrate for collagenase
Sigma-Aldrich
IV型コラーゲン ヒト細胞培養液由来, Bornstein and Traub Type IV, 0.3 mg/mL, sterile-filtered, BioReagent, suitable for cell culture
Sigma-Aldrich
コラーゲン from calf skin, Bornstein and Traub Type I, (0.1% solution in 0.1 M acetic acid), aseptically processed, BioReagent, suitable for cell culture
Sigma-Aldrich
コラーゲン ニワトリ胸骨軟骨由来, Type II (Miller), powder, BioReagent, suitable for cell culture
Sigma-Aldrich
コラーゲン ヒト胎盤由来, Bornstein and Traub Type I (Sigma Type VIII), powder
Sigma-Aldrich
コラーゲン EHS肉腫基底膜由来, Type IV (Miller), lyophilized powder, BioReagent, suitable for cell culture
Sigma-Aldrich
コラーゲン ウシ気管軟骨由来, Bornstein and Traub Type II, powder
Sigma-Aldrich
コラーゲン ヒト, Bornstein and Traub Type I, acid soluble, powder, ~95% (SDS-PAGE)
Sigma-Aldrich
コラーゲン ウシ鼻中隔由来, Bornstein and Traub Type II, powder
Sigma-Aldrich
コラーゲン ヒト胎盤由来, Bornstein and Traub Type III (Sigma Type X), powder
Sigma-Aldrich
コラーゲン ヒト胎盤由来, Bornstein and Traub Type IV, solution, suitable for cell culture, High Performance
Sigma-Aldrich
コラーゲン ヒト胎盤由来, Bornstein and Traub Type V (Sigma Type IX), powder
Sigma-Aldrich
コラーゲン ヒト胎盤由来, Bornstein and Traub Type IV, powder
Sigma-Aldrich
コラーゲン ウサギ皮膚由来, Bornstein and Traub Type I, powder